A correspondence by appointment. We engage with rigour, discretion, and a deliberate restraint — and we welcome those whose values align with our own.
LONGEV'AI · Clinical Intelligence does not seek volume. We seek alignment of values, depth of expertise, and seriousness of purpose. The institutions and individuals who become part of our trajectory bring more than capital or contracts: they bring rigour, networks of clinical excellence, and a shared belief that AI in medicine should preserve, not replace, the human judgment at its core.
Directors, founders and senior physicians of premium aesthetic, regenerative medicine, clinical longevity and medicalized spa & wellness clinics who recognise the strategic value of an AI-native operations layer — and seek a partner capable of preserving the cultural sophistication and discretion their patients demand.
Tier-one healthcare and technology funds, family offices, and strategic corporate investors with a serious mandate in healthcare technology and a willingness to support a deliberate, disciplined trajectory rather than a velocity-first one. Investor materials are shared exclusively under signed non-disclosure agreement.
Senior operators in regional development, distribution networks across our priority geographies (Europe, GCC, MENA), regulatory experts in EU and Swiss frameworks, and clinical advisors capable of representing our work to peer institutions of comparable seriousness.
Senior medical professionals — practitioners, researchers and clinical leaders — whose insight enriches the architectural decisions we make. Membership of our Medical Advisory Board is selective, by invitation, and formalised under structured engagement letters.
We do not publish our partner list. We do not announce engagements without consent. We do not use our partners as marketing material. Discretion is structural.· Engagement principles ·
Each conversation begins with a signed non-disclosure agreement and a private, time-bound exchange of materials. Every inquiry is read by a member of the founding team and answered personally within two business days.
If you are reading this with a serious intent to collaborate — as principal, as investor, as advisor, as partner — we welcome your message.
Direct correspondence is welcomed at contact@longevai.ch. Strategic and confidential channels are accessible from the contact page. Every conversation begins with mutual confidentiality.
